Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-29

Clinical Trial Update: Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study

View source ↗

Summary

A longitudinal study investigating dysregulation of whole-body metabolism in ovarian cancer is currently recruiting. The study is sponsored by the University of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Tennessee Graduate School of Medicine | Conditions: Ovary Cancer | Status: RECRUITING